Patents
Patents are exclusive rights granted for an invention, an invention refers to a solution to a specific problem in the field of technology. It can be a new and useful art, process, machine, manufacture, or composition of matter. The invention should not be obvious and should have practical applications in trade or industry. It can also include any new and useful improvement on existing inventions. An invention may be related to a product or a process and encompasses alleged inventions that may require examination or verification. (Industrial Property Act, Act No.3 of 2001).
| Application Number |
Title of the Invention |
Applicant |
Nationality |
Body |
Area of technology |
| 2017/10087 |
CONTEXTS FOR LARGE CODING TREE UNITS |
QUALCOMM INCORP... |
USA |
JURISTIC |
H 04N 19/119, H 04N 19/96, H 04N 19/196, H 04N 19/13 |
| 2014/7478 |
: IMPROVEMENTS IN LOCKERS |
FSP HOLDINGS PT... |
AUSTRALIA |
JURISTIC |
A 47B 47/00, A 47B 96/00, A 47B 57/10, A 47B 57/00 |
| 2017/10091 |
COMPOSITION CONTAINING CHITIN AND DIGESTIBLE PROTEINS |
QUALCOMM INCORP... |
USA |
JURISTIC |
A 23L 33/17 |
| 2017/9987 |
NOVEL CRYSTAL FORMS OF THE MONOSODIUM SALT OF FORAMSULFURON |
BAYER CROPSCIEN... |
GERMANY |
JURISTIC |
A 01N 47/36, A 01P 13/00, A 01P 21/00, C 07D 239/52 |
| 2017/10136 |
5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAM... |
LES LABORATOIRE... |
BELGIUM |
JURISTIC |
C 07D 403/06, A 61K 31/496, A 61P 19/04, A 61P 19/02 |
| 2017/9955 |
ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LPXC INHIBITORS |
: NOVARTIS AG |
SWITZERLAND |
JURISTIC |
C 07D 261/08, C 07D 413/12, C 07D 413/06, A 61K 31/42 |
| 2017/10175 |
PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL-N^-(1-METHYLETH... |
ASTEX THERAPEUT... |
UK |
JURISTIC |
C 07D 403/04, A 61K 47/18, A 61K 9/48, A 61K 31/498, A 61K 9/20, A 61P 35/00 |
| 2016/9445 |
MUSCARINIC RECEPTOR AGONISTS |
HEPTARES THERAP... |
UNITED KINGDOM |
JURISTIC |
C 07D 519/00, C 07D 471/10, C 07D 498/10, A 61K 31/444, A 61K 31/55, A 61P 25/00 |
| 2017/10191 |
TOLL-LIKE RECEPTOR MODULATING 4,6-DIAMINO-PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS |
GILEAD SCIENCES... |
USA |
JURISTIC |
C 07D 471/04, A 61K 31/519, A 61P 37/00, A 61P 35/00, A 61P 29/00, A 61P 31/12 |
| 2017/10063 |
QUINAZOLINE DERIVATIVES USED TO TREAT HIV |
GILEAD SCIENCES... |
USA AND CZECH REPUBLIC |
JUIRSTIC |
: C 07D 401/12, C 07D 239/94, A 61K 31/517, A 61P 31/18 |
| 2017/10208 |
β-D-2^-DEOXY-2^α-FLUORO-2^-β-C-SUBSTITUTED-2-MODIFIED-N�-SUBSTITUTED PUR... |
ATEA PHARMACEUT... |
USA |
JURISTIC |
C 07H 19/16, A 61K 31/7076 |
| 2017/9757 |
IRON-FORTIFIED EDIBLE OIL-AND-WATER EMULSION |
UPFIELD EUROPE ... |
THE NETHERLANDS |
JURISTIC |
A 23D 7/005, A 23L 1/304 |
|
